Eugastro Gmbh
About Eugastro Gmbh
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
7
Gilead Sciences
7
Takeda
5
Janssen Research & Development, LLC
4
Arrowhead Pharmaceuticals
3
Galapagos NV
3
Genfit
2
Intercept Pharmaceuticals
2
Calliditas Therapeutics Suisse SA
1
Conatus Pharmaceuticals Inc.
1
Cristcot LLC
1
Clinical Trials at Eugastro Gmbh
During the past decade, Eugastro Gmbh conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 22 clinical trials were completed, i.e. on
average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)
2013-03-04
2016-08-24
Completed
235
Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
2012-12-05
2016-12-29
Terminated
222
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH
2012-10-29
2017-01-03
Terminated
259
A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
2015-04-29
2018-05-22
Completed
247
Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease
2015-04-30
2016-12-22
Terminated
187
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
2015-12-02
2025-02-27
Active, not recruiting
878
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Eugastro Gmbh" #1 sponsor was "Celgene" with 7 trials, followed by "Gilead Sciences" with 7 trials
sponsored, "Takeda" with 5 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "Arrowhead Pharmaceuticals"
with 4 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Eugastro Gmbh"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "ClinIntel" with 1 trials as a collaborator, "Clinical Reference Laboratory" with 1 trials as a collaborator and "Cristcot HCA LLC" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at Eugastro Gmbh
According to Clinical.Site data, the most researched conditions in "Eugastro Gmbh" are
"Crohn's Disease" (9 trials), "Ulcerative Colitis" (6 trials), "Colitis, Ulcerative" (4 trials), "Crohn Disease" (3 trials) and "Hepatitis B" (3 trials). Many other conditions were trialed in "Eugastro Gmbh" in a lesser frequency.
Clinical Trials Intervention Types at Eugastro Gmbh
Most popular intervention types in "Eugastro Gmbh" are "Drug" (38 trials), "Biological" (5 trials), "Other" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "Filgotinib" (4 trials), "GED-0301" (3 trials), "Guselkumab" (3 trials) and "antihistamine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Eugastro Gmbh
The vast majority of trials in "Eugastro Gmbh" are
43 trials for "All" genders.
Clinical Trials Status at Eugastro Gmbh
Currently, there are NaN active trials in "Eugastro Gmbh".
undefined are not yet recruiting,
9 are recruiting,
6 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 13 completed trials in Eugastro Gmbh,
undefined suspended trials,
and 13 terminated clinical trials to date.
Out of the total trials that were conducted in Eugastro Gmbh, 0 "Phase 1"
clinical trials were conducted, 18 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".